安图生物股价涨5.98%，长江资管旗下1只基金重仓，持有7.1万股浮盈赚取15.83万元

Group 1 - The core viewpoint of the news is that Antu Biology's stock has increased by 5.98%, reaching a price of 39.54 yuan per share, with a trading volume of 260 million yuan and a turnover rate of 1.20%, resulting in a total market capitalization of 22.594 billion yuan [1] - Antu Biology, established on September 15, 1999, and listed on September 1, 2016, specializes in the research, production, and sales of in vitro diagnostic reagents and instruments, with its main business revenue composition being 86.63% from reagents, 10.99% from instruments, 1.40% from other sources, and 0.98% from maintenance income [1] - Changjiang Asset Management holds a significant position in Antu Biology through its fund, Changjiang Xuri Mixed A (021015), which held 71,000 shares in the fourth quarter, accounting for 2.47% of the fund's net value, ranking as the tenth largest holding [1] Group 2 - The fund manager of Changjiang Xuri Mixed A (021015) is Shi Zhan, who has been in the position for 4 years and 30 days, with the fund's total asset size being 802 million yuan [2] - During Shi Zhan's tenure, the best fund return was 53.53%, while the worst return was 48.76% [2]